| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
56.72
|
|
2
|
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
50.94
|
|
3
|
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
41.47
|
|
4
|
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
26.95
|
|
5
|
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
|
Circulation
|
2003
|
23.97
|
|
6
|
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
11.32
|
|
7
|
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.
|
JAMA
|
2013
|
10.43
|
|
8
|
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.
|
Lancet
|
2014
|
10.06
|
|
9
|
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
|
Lancet
|
2015
|
7.99
|
|
10
|
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.
|
Lancet
|
2013
|
7.03
|
|
11
|
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.
|
Lancet
|
2015
|
6.13
|
|
12
|
Heart failure-related hospitalization in the U.S., 1979 to 2004.
|
J Am Coll Cardiol
|
2008
|
5.65
|
|
13
|
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.
|
Circulation
|
2013
|
4.60
|
|
14
|
Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council.
|
Circulation
|
2006
|
3.93
|
|
15
|
Health Effects of Overweight and Obesity in 195 Countries over 25 Years.
|
N Engl J Med
|
2017
|
3.90
|
|
16
|
Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group.
|
Circulation
|
2008
|
3.56
|
|
17
|
Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000.
|
Circulation
|
2003
|
3.39
|
|
18
|
The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study.
|
Circulation
|
2014
|
2.99
|
|
19
|
Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study.
|
Circulation
|
2014
|
2.66
|
|
20
|
Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.
|
Circulation
|
2003
|
2.61
|
|
21
|
NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025.
|
Am J Respir Crit Care Med
|
2015
|
2.60
|
|
22
|
Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000.
|
Arch Intern Med
|
2004
|
2.52
|
|
23
|
American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science.
|
Circulation
|
2003
|
2.49
|
|
24
|
Physician advice, patient actions, and health-related quality of life in secondary prevention of stroke through diet and exercise.
|
Stroke
|
2002
|
2.14
|
|
25
|
When chronic conditions become acute: prevention and control of chronic diseases and adverse health outcomes during natural disasters.
|
Prev Chronic Dis
|
2005
|
2.03
|
|
26
|
World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic.
|
Circulation
|
2002
|
2.02
|
|
27
|
Pulmonary hypertension surveillance--United States, 1980-2002.
|
MMWR Surveill Summ
|
2005
|
1.91
|
|
28
|
Genomics and the prevention and control of common chronic diseases: emerging priorities for public health action.
|
Prev Chronic Dis
|
2005
|
1.84
|
|
29
|
Low public recognition of major stroke symptoms.
|
Am J Prev Med
|
2003
|
1.84
|
|
30
|
Demographic and epidemiologic drivers of global cardiovascular mortality.
|
N Engl J Med
|
2015
|
1.70
|
|
31
|
Increased atrial fibrillation mortality: United States, 1980-1998.
|
Am J Epidemiol
|
2002
|
1.63
|
|
32
|
Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998.
|
Stroke
|
2002
|
1.62
|
|
33
|
Disparities in cardiac care: rising to the challenge of Healthy People 2010.
|
J Am Coll Cardiol
|
2004
|
1.59
|
|
34
|
Overreporting of deaths from coronary heart disease in New York City hospitals, 2003.
|
Prev Chronic Dis
|
2010
|
1.54
|
|
35
|
Trends in self-reported multiple cardiovascular disease risk factors among adults in the United States, 1991-1999.
|
Arch Intern Med
|
2004
|
1.47
|
|
36
|
Evidence-based approach for disaster preparedness authorities to inform the contents of repositories for prescription medications for chronic disease management and control.
|
Prehosp Disaster Med
|
2009
|
1.46
|
|
37
|
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview.
|
Circulation
|
2004
|
1.44
|
|
38
|
High blood pressure: the foundation for epidemic cardiovascular disease in African populations.
|
Ethn Dis
|
2003
|
1.44
|
|
39
|
Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000.
|
Am Heart J
|
2005
|
1.39
|
|
40
|
Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention.
|
Circulation
|
2006
|
1.39
|
|
41
|
Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.
|
J Am Coll Cardiol
|
2013
|
1.32
|
|
42
|
A legal framework for preventing cardiovascular diseases.
|
Am J Prev Med
|
2005
|
1.30
|
|
43
|
Screening and assessment of coronary heart disease in HIV-infected patients.
|
Circulation
|
2008
|
1.29
|
|
44
|
Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.
|
Circulation
|
2006
|
1.28
|
|
45
|
Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010.
|
Glob Heart
|
2012
|
1.26
|
|
46
|
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
|
Circulation
|
2004
|
1.25
|
|
47
|
Public recognition of major signs and symptoms of heart attack: seventeen states and the US Virgin Islands, 2001.
|
Am Heart J
|
2004
|
1.25
|
|
48
|
Impact of stroke on health-related quality of life in the noninstitutionalized population in the United States.
|
Stroke
|
2006
|
1.24
|
|
49
|
Changes in health behaviors among older Americans, 1990 to 2000.
|
Public Health Rep
|
2004
|
1.14
|
|
50
|
Racial/ethnic differences in microalbuminuria among adults with prehypertension and hypertension: National Health and Nutrition Examination Survey (NHANES), 1999-2006.
|
Am J Hypertens
|
2010
|
1.10
|
|
51
|
Tooth loss and heart disease: findings from the Behavioral Risk Factor Surveillance System.
|
Am J Prev Med
|
2005
|
1.08
|
|
52
|
Sodium intake among people with normal and high blood pressure.
|
Am J Prev Med
|
2005
|
1.08
|
|
53
|
Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on Cardiovascular Nursing and Stroke Council.
|
J Cardiovasc Nurs
|
2007
|
1.05
|
|
54
|
Major multinational food and beverage companies and informal sector contributions to global food consumption: implications for nutrition policy.
|
Global Health
|
2011
|
1.05
|
|
55
|
Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study.
|
Neuroepidemiology
|
2015
|
1.04
|
|
56
|
Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013.
|
Neuroepidemiology
|
2015
|
1.02
|
|
57
|
Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.
|
Circulation
|
2013
|
1.01
|
|
58
|
Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States.
|
Am Heart J
|
2006
|
1.00
|
|
59
|
Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study.
|
Neuroepidemiology
|
2015
|
0.99
|
|
60
|
Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010.
|
Glob Heart
|
2012
|
0.99
|
|
61
|
Epidemiology of pacemaker procedures among Medicare enrollees in 1990, 1995, and 2000.
|
Am J Cardiol
|
2005
|
0.98
|
|
62
|
Pathogenesis and clinical physiology of hypertension.
|
Cardiol Clin
|
2010
|
0.97
|
|
63
|
Factors associated with the prevalence of hypertension in the southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.96
|
|
64
|
Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.
|
J Am Coll Cardiol
|
2006
|
0.95
|
|
65
|
Variations in ischemic heart disease burden by age, country, and income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 study.
|
Glob Heart
|
2014
|
0.95
|
|
66
|
Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study.
|
Neuroepidemiology
|
2015
|
0.94
|
|
67
|
Cardiopulmonary responses to exercise in women with sickle cell anemia.
|
Am J Respir Crit Care Med
|
2002
|
0.94
|
|
68
|
Public health surveillance for disease prevention: lessons from the behavioral risk factor surveillance system.
|
Ethn Dis
|
2003
|
0.92
|
|
69
|
Population aging and implications for epidemic cardiovascular disease in Sub-Saharan Africa.
|
Ethn Dis
|
2003
|
0.91
|
|
70
|
Stroke Prevention Worldwide - What Could Make It Work?
|
Neuroepidemiology
|
2015
|
0.89
|
|
71
|
Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013.
|
Neuroepidemiology
|
2015
|
0.88
|
|
72
|
ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.
|
J Am Coll Cardiol
|
2009
|
0.88
|
|
73
|
Establishing data elements for the Paul Coverdell National Acute Stroke Registry: Part 1: proceedings of an expert panel.
|
Stroke
|
2003
|
0.88
|
|
74
|
Atrial fibrillation: public health implications.
|
Am J Prev Med
|
2005
|
0.88
|
|
75
|
Causes of Death Data in the Global Burden of Disease Estimates for Ischemic and Hemorrhagic Stroke.
|
Neuroepidemiology
|
2015
|
0.87
|
|
76
|
Assessment of commonly available education materials in heart failure clinics.
|
J Cardiovasc Nurs
|
2012
|
0.87
|
|
77
|
Prevalence of self-reported high blood pressure awareness, advice received from health professionals, and actions taken to reduce high blood pressure among US adults--Healthstyles 2002.
|
J Clin Hypertens (Greenwich)
|
2005
|
0.87
|
|
78
|
Race, sex, and age differences in heart failure-related hospitalizations in a southern state: implications for prevention.
|
Circ Heart Fail
|
2010
|
0.86
|
|
79
|
Out-of-hospital cardiac deaths in adolescents and young adults in the United States, 1989 to 1998.
|
Am J Prev Med
|
2005
|
0.86
|
|
80
|
Smoking among adults with coronary heart disease.
|
Prev Med
|
2006
|
0.85
|
|
81
|
Disparities in hypertension-related mortality among selected Hispanic subgroups and non-Hispanic White women ages 45 years and older--United States, 1995-1996 and 2001-2002.
|
Ethn Dis
|
2007
|
0.85
|
|
82
|
Looking through a glass, darkly: eliminating health disparities.
|
Prev Chronic Dis
|
2006
|
0.83
|
|
83
|
Development of systems of care for ST-elevation myocardial infarction patients: the patient and public perspective.
|
Circulation
|
2007
|
0.82
|
|
84
|
Combination pharmacotherapy for cardiovascular disease prevention: threat or opportunity for public health?
|
Am J Prev Med
|
2005
|
0.81
|
|
85
|
Use of BRFSS data and GIS technology for rapid public health response during natural disasters.
|
Prev Chronic Dis
|
2008
|
0.81
|
|
86
|
Carotid adventitial vasa vasorum and intima-media thickness in a primary prevention population.
|
Echocardiography
|
2014
|
0.81
|
|
87
|
Vascular endothelium summary statement V: Pulmonary hypertension and acute lung injury: public health implications.
|
Vascul Pharmacol
|
2006
|
0.80
|
|
88
|
The role of diets, food, and nutrients in the prevention and control of hypertension and prehypertension.
|
Cardiol Clin
|
2010
|
0.79
|
|
89
|
Eliminating health disparities: the time for action is now.
|
Ethn Dis
|
2002
|
0.79
|
|
90
|
Summary statement IV: Obesity and diabetes: opportunities for translation of basic research.
|
Vascul Pharmacol
|
2006
|
0.79
|
|
91
|
ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.
|
Circulation
|
2009
|
0.79
|
|
92
|
Tobacco use and the cardiovascular disease epidemic in developing countries: global crises and opportunity in the making.
|
Ethn Dis
|
2003
|
0.79
|
|
93
|
Health promotion and cardiovascular disease prevention in sub-Saharan Africa.
|
Prog Cardiovasc Dis
|
2013
|
0.78
|
|
94
|
Geographic variations in heart failure hospitalizations among medicare beneficiaries in the Tennessee catchment area.
|
Am J Med Sci
|
2012
|
0.78
|
|
95
|
Vascular endothelium summary statement I: Health promotion and chronic disease prevention.
|
Vascul Pharmacol
|
2006
|
0.78
|
|
96
|
High blood pressure in children and adolescents: to treat or not to treat is not the question.
|
J Clin Hypertens (Greenwich)
|
2008
|
0.77
|
|
97
|
Increasing trends in pre-transport stroke deaths--United States, 1990-1998.
|
Ethn Dis
|
2003
|
0.77
|
|
98
|
Task force #5--the role of cardiovascular specialists as leaders in prevention: from training to champion. 33rd Bethesda Conference.
|
J Am Coll Cardiol
|
2002
|
0.77
|
|
99
|
Electrocardiographic recording and timeliness of clinician evaluation in the emergency department in patients presenting with chest pain.
|
Am J Cardiol
|
2007
|
0.77
|
|
100
|
The United Nations high level meeting addresses noncommunicable diseases, but where is hypertension?
|
J Clin Hypertens (Greenwich)
|
2011
|
0.77
|
|
101
|
The heart, kidney, and brain as target organs in hypertension.
|
Curr Probl Cardiol
|
2003
|
0.77
|
|
102
|
Trends in hypertension-related death in the United States: 1980-1998.
|
J Clin Hypertens (Greenwich)
|
2004
|
0.77
|
|
103
|
Trends in hospitalization for the implantation of cardioverter-defibrillators in the United States, 1990-2005.
|
Am J Cardiol
|
2008
|
0.76
|
|
104
|
Using behavioral risk factor surveillance data for heart disease and stroke prevention programs.
|
Am J Prev Med
|
2005
|
0.76
|
|
105
|
Public health and the control of high blood pressure at the state level: asleep at the switch or running low on fuel?
|
Circulation
|
2008
|
0.76
|
|
106
|
Public health: Cardiovascular disease insights--something new out of Africa.
|
Nat Rev Cardiol
|
2013
|
0.75
|
|
107
|
Industry response to the obesity threat.
|
JAMA
|
2011
|
0.75
|
|
108
|
Fifth Pivotal Research in Cardiology in the Elderly (PRICE-V) symposium: preventive cardiology in the elderly-executive summary. Part I: morning session.
|
Prev Cardiol
|
2009
|
0.75
|
|
109
|
Fantastic voyage through cardiology: from 1969 to 2008.
|
J Am Coll Cardiol
|
2009
|
0.75
|
|
110
|
Fifth Pivotal Research in Cardiology in the Elderly (PRICE-V) Symposium: Preventive Cardiology in the Elderly--executive summary. Part II: afternoon session.
|
Prev Cardiol
|
2010
|
0.75
|
|
111
|
Rehabilitation referral revisited: rhyme, reason, and response.
|
J Cardiopulm Rehabil
|
2004
|
0.75
|
|
112
|
Pathogenesis and clinical physiology of hypertension.
|
Cardiol Clin
|
2002
|
0.75
|
|
113
|
Strategies to Improve Stroke Care Services in Low- and Middle-Income Countries: A Systematic Review.
|
Neuroepidemiology
|
2017
|
0.75
|
|
114
|
Global cardiovascular disease prevention: a call to action for nursing. Foreword.
|
Eur J Cardiovasc Nurs
|
2011
|
0.75
|
|
115
|
Cardiovascular health. Cardiovascular epidemiology and the role of prevention: what do we know and what must we do?
|
Ethn Dis
|
2002
|
0.75
|
|
116
|
Building bridges: a partnership between professional nursing and the Centers for Disease Control and Prevention to reduce the burden of heart disease and stroke.
|
Am J Prev Med
|
2005
|
0.75
|
|
117
|
Clinical hypertension.
|
Cardiol Clin
|
2002
|
0.75
|
|
118
|
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
|
J Am Coll Cardiol
|
2007
|
0.75
|
|
119
|
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases.
|
Circulation
|
2007
|
0.75
|
|
120
|
Controlling high blood pressure: the art of the soluble and the hope of progress.
|
J Clin Hypertens (Greenwich)
|
2007
|
0.75
|
|
121
|
Assessing laws and legal authorities for public health emergency legal preparedness.
|
J Law Med Ethics
|
2008
|
0.75
|
|
122
|
Using outcome measures to monitor the performance of the National Heart Disease and Stroke Prevention Program: current capabilities and future challenges.
|
Am J Prev Med
|
2005
|
0.75
|
|
123
|
Initial clinical encounter with the patient with established hypertension.
|
Cardiol Clin
|
2010
|
0.75
|
|
124
|
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
|
Circulation
|
2007
|
0.75
|
|
125
|
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
|
J Am Coll Cardiol
|
2007
|
0.75
|
|
126
|
ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases.
|
J Am Coll Cardiol
|
2007
|
0.75
|
|
127
|
Global cardiovascular disease prevention: a call to action for nursing.
|
J Cardiovasc Nurs
|
2011
|
0.75
|
|
128
|
Preface: Preventive cardiology in the elderly.
|
Clin Geriatr Med
|
2009
|
0.75
|